Aquestive Therapeutics (AQST) Stock Analysis & Winston Score

Aquestive Therapeutics is a small pharmaceutical company that makes medicines designed to dissolve under the tongue or inside the cheek, so patients don't need to swallow a pill or get an injection. Its main product is Libervant, a dissolvable film strip used to treat seizure clusters in epilepsy patients. The company also licenses its film-based drug delivery technology to larger pharmaceutical partners, who use it to make their own medicines. Aquestive earns money two ways: selling its own branded drugs directly and collecting royalties and licensing fees from partners who use its proprietary PharmFilm technology. It operates primarily in the United States and is a small company with a market cap around $500 million. The high gross margin reflects the value of its technology platform, but the deeply negative operating margin shows it is still spending far more than it earns. The key risk is whether Libervant can gain enough market share in epilepsy treatment to move the company toward profitability.